Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

AmerisourceBergen Corp., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016
Net income (loss)
Depreciation, including amounts charged to cost of goods sold
Amortization, including amounts charged to interest expense
Provision (benefit) for credit losses
Provision (benefit) for deferred income taxes
Share-based compensation expense
LIFO expense (credit)
Impairment of assets, including goodwill
Gain on sale of businesses
Turkey highly inflationary impact
Gain on sale of an equity investment
Gain on remeasurement of equity investment
Impairment of non-customer note receivable
Loss on consolidation of equity investments
Loss on early retirement of debt
Other, net
Accounts receivable
Inventories
Income tax receivable
Prepaid expenses and other assets
Accounts payable
Accrued expenses
Long-term accrued litigation liability
Income taxes payable and other liabilities
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Capital expenditures
Cost of acquired companies, net of cash acquired
Cost of equity investments
Proceeds from sale of property and equipment
Proceeds from sale of businesses
Proceeds from sales of investment securities available-for-sale
Purchases of investment securities available-for-sale
Other, net
Net cash used in investing activities
Senior notes and loan borrowings
Senior notes and loan repayments
Borrowings under revolving and securitization credit facilities
Repayments under revolving and securitization credit facilities
Payment of premium on early retirement of debt
Purchases of common stock
Exercises of stock options
Cash dividends on common stock
Profarma retail equity offering
Employee tax withholdings related to restricted share vesting
Other, net
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Increase (decrease) in cash, cash equivalents, and restricted cash, including cash classified within assets held for sale
(Increase) decrease in cash classified within assets held for sale
Increase (decrease) in cash, cash equivalents, and restricted cash

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).


The data reflects substantial volatility and notable fluctuations across key financial metrics over the periods analyzed. Several trends and significant observations emerge from the various items reported.

Net income (loss)

There is a highly irregular pattern in net income, characterized by alternating periods of strong profitability and significant losses. For example, the company reported very high net income in December 2017 and March 2020 but experienced a sharp loss in September 2020, the largest negative figure in the series. Following this, positive net incomes resumed but with notable fluctuations quarter-to-quarter, indicating inconsistent earnings performance.

Depreciation and Amortization

Depreciation expenses increased steadily over time with some variability, generally rising from about 63,000 to over 100,000 US$ thousands by mid-2023, reflecting growing asset bases or revised estimates of asset life. Amortization fluctuated more dramatically, initially stable, then sharply peaking in 2021 and 2023 periods. This suggests episodic recognition of intangible assets or changes in amortization schedules.

Provision for Credit Losses and Deferred Income Taxes

The provision for credit losses shows inconsistency, with positive and negative values, indicating fluctuating expectations of default risk or write-offs. The deferred income tax provision reveals extreme variation, including a large tax benefit in late 2017 and a dramatic tax-related expense or benefit in 2020, suggesting significant tax event impacts, possibly due to changes in tax law or one-time adjustments.

Impairment and Gains/Losses on Investments

Several large impairments are noted, including goodwill impairment in notable quarters around 2018 and substantial asset impairments in 2020 and 2022, indicating write-downs affecting earnings. Gains on sales of businesses and equity investments also appear sporadically, including significant gains in late 2022, signifying strategic divestitures. Offsetting these, there are losses related to equity investments and early retirement of debt, highlighting episodic non-operating financial impacts.

Operating Cash Flow and Working Capital

Net cash provided by operating activities generally trends positive, with occasional declines. Significant spikes in operating cash inflows correspond with periods of large net income gains or non-cash adjustments. Changes in working capital accounts (accounts receivable, inventories, and accounts payable) exhibit extremely high volatility, with recurring large positive and negative values each quarter. This reflects substantial fluctuations in operational liquidity and potential timing differences in cash collections and payments.

Capital Expenditures and Investing Activities

Capital expenditures consistently represent a considerable cash outflow each quarter, ranging mostly between 65,000 to 175,000 US$ thousands, evidencing sustained investment in property, plant, and equipment. Net cash used in investing activities also shows marked variation, including periods of very large outflows associated with acquisitions and investments, particularly around 2018-2020 and in 2022, balancing some cash inflows from asset sales.

Financing Activities

Cash flows from financing activities demonstrate active management of debt and equity. There are recurring borrowings and repayments under revolving credit facilities and term loans, with large borrowings notably in 2021 and 2023. The pattern of stock repurchases is evident with substantial outflows at various points, partially offset by proceeds from stock option exercises. Cash dividends paid steadily increase over time, signifying consistent shareholder returns despite fluctuations in other areas.

Balance Sheet-Related Operational Items

Accounts receivable and inventories fluctuate widely, indicating variability in billing, collections, and stock levels. Accounts payable shows occasional very large positive and negative swings linked possibly to supplier payment timings or adjustments. Some items like accrued expenses and long-term accrued litigation liabilities show periodic spikes, implying episodic financial obligations or settlements.

Foreign Exchange and Non-Recurring Items

Occasional quantifiable effects from exchange rate changes appear late in the data, likely impacting cash balances and earnings. Certain one-time items such as Turkey highly inflationary impacts and losses on consolidation of equity investments surface sporadically, pointing to exposure in specific markets or unique financial events.

Overall Cash Position Changes

The net increase or decrease in cash and cash equivalents experiences significant swings, sometimes exceeding one billion US$ in absolute terms. The data reveals cycles of strong cash inflow following operational profitability and investing divestitures, contrasted with steep declines related to investing outlays, debt repayments, and share repurchases.

In summary, the financial data illustrates a company with variable profitability affected by significant non-recurring events, such as impairments and gains/losses on investments, combined with active debt and equity financing strategies. Operational cash flow remains generally positive but influenced heavily by volatile working capital changes. Capital investment is sustained and substantial, while financing activities show strategic debt management and shareholder returns continuation. The overall financial profile suggests a dynamic environment with episodic challenges and capital allocation decisions affecting net income and cash flow results over the periods presented.